PATRICK SPENCER: Open Payments
NPI 1013164110 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,301 in 32 payments from 9 companies in 2025. Trend: 2023 $1,510 · 2024 $1,381 · 2025 $1,301
Food & beverage: $1,202Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $446 |
| GENZYME CORPORATION | 7 | $240 |
| Legend Biotech USA Inc. | 2 | $143 |
| Kite Pharma, Inc. | 1 | $139 |
| Karyopharm Therapeutics Inc. | 4 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $85 |
| PFIZER INC. | 3 | $57 |
| Adaptive Biotechnologies Corporation | 2 | $49 |
| Amgen Inc. | 2 | $38 |
Products named: CARVYKTI, SARCLISA, RYBREVANT, XPOVIO, DARZALEX, NINLARO, ELREXFIO, clonoSEQ.
Industry payments across NY — which companies pay providers there.
